Sound Income Strategies’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-521
Closed -$32.3K 739
2026
Q1
$32.3K Sell
521
-982
-65% -$78.6K ﹤0.01% 989
2025
Q4
$132K Buy
1,503
+459
+44% +$45K 0.01% 513
2025
Q3
$102K Buy
1,044
+792
+314% +$82K 0.01% 402
2025
Q2
$27.1K Buy
252
+120
+91% +$12.1K ﹤0.01% 677
2025
Q1
$13.3K Buy
132
+100
+313% +$10.1K ﹤0.01% 822
2024
Q4
$2.86K Sell
32
-87
-73% -$7.66K ﹤0.01% 1101
2024
Q3
$9.99K Buy
119
+33
+38% +$2.6K ﹤0.01% 793
2024
Q2
$6.64K Buy
86
+77
+856% +$5.64K ﹤0.01% 873
2024
Q1
$616 Buy
+9
New +$579 ﹤0.01% 1219
2023
Q1
Sell
-11
Closed -$509 1064
2022
Q4
$509 Hold
11
﹤0.01% 908
2022
Q3
$0 Hold
11
﹤0.01% 886
2022
Q2
$0 Hold
11
﹤0.01% 889
2022
Q1
$0 Buy
+11
New +$477 ﹤0.01% 876
2020
Q3
Sell
-73
Closed -$3K 843
2020
Q2
$3K Buy
+73
New +$2.63K ﹤0.01% 568

Other funds holding BSX

Sound Income Strategies's BSX Position: Q2 2026 in Review

Sound Income Strategies sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 521 shares — an estimated $32.3K sold.

Sound Income Strategies first reported a position in BSX in Q2 2020 and held it in 14 quarters. The position peaked at $132K in Q4 2025. 1,039 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Sound Income Strategies reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 521 Boston Scientific shares in Q2 2026, an estimated $32.3K.
  • Sound Income Strategies first reported a position in Boston Scientific in Q2 2020 and held it in 14 quarters.
  • Sound Income Strategies's Boston Scientific position peaked at $132K in Q4 2025.
  • 1,039 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.